Immunotherapy Sensitivity of Mismatch Repair-Deficient Cancer: Mutation Load Is Not Enough.
View/ Open
Date
2021-01-11ICR Author
Author
Gerlinger, M
Type
Journal Article
Metadata
Show full item recordAbstract
Abundant neoantigens are considered responsible for the immunotherapy sensitivity of mismatch repair-deficient (MMRd) cancers. In this issue of Cancer Cell, two papers show that MLH1 mismatch repair gene loss promotes cGAS-STING activation, interferon secretion, and T cell priming. This may be essential for the high immunotherapy sensitivity in MMRd cancer.
Collections
Research team
Translational Oncogenomics
Translational Oncogenomics
Language
eng
Date accepted
2020-12-07
Citation
Cancer cell, 2021, 39 (1), pp. 16 - 18
Publisher
CELL PRESS